期刊文献+

雌激素受体及其变异体与子宫内膜癌的关系 被引量:4

Relationship between Estrogen Receptor and Its Variants with Endometrial Cancer
下载PDF
导出
摘要 经典雌激素受体(ER)及其变异体、雌激素膜受体(m ER)参与介导雌激素不同生物效应。多项研究表明,雌激素与子宫内膜癌的发生、发展过程密切相关,目前普遍接受的子宫内膜癌形成的原因是子宫内膜受到过度雌激素刺激并缺乏孕激素拮抗。雌激素发挥其效应主要依赖ER,研究ER对了解子宫内膜癌发生、发展的可能机制起到了重要作用,并为子宫内膜癌的诊断及治疗提供了新的思路。综述ER及其变异体的结构、功能及其与子宫内膜癌的关系,为深入研究提供思路。 The classical estrogen receptor (ER) and its variants,membrane estrogen receptor (mER) involved in mediating different signaling effects of estrogen. Studies have shown estrogen is closely related to the occurrence and development process of endometrial cancer ,while excessive estrogen stimulation and lack of progesterone antagonist is widely accepted as the main cause of endometrial cancer and the function of estrogen is mediated by estrogen receptor. Learning the possible mechanisms of the occurrence and development of endometrial cancer and finding new ways for its diagnosis and treatment through estrogen receptor also showing great significance. This paper reviews the structure and function of estrogen receptor,and analyses its relationship with endometrial cancer.
出处 《国际妇产科学杂志》 CAS 2014年第6期599-602,共4页 Journal of International Obstetrics and Gynecology
关键词 受体 雌激素 雌激素受体Α 雌激素受体Β 子宫内膜肿瘤 Receptors,estrogen Estrogen receptor alpha Estrogen receptor beta Endometrial neoplasms
  • 相关文献

参考文献20

  • 1Pike AC,Brzozowski AM,Hubbard RE. A structural biologist's viewof the oestrogen receptor [J]. J Steroid Biochem Mol Biol,2000,74.5):261-268.
  • 2Herynk MH,Fuqua SA. Estrogen receptor mutations in human disease[J]. EndocrRev,2004,25(6):869-898.
  • 3Filardo EJ,Thomas P. Minireview:G protein -coupled estrogenreceptor -1, GPER -1 : its mechanism of action and role in femalereproductive cancer, renal and vascular physiology [J].Endocrinology,2012,153(7):2953-2962.
  • 4Sivridis E,Ciatromanolaki A. The pathogenesis of endometrialcarcinomas at menopause : facts and figures [J], J Clin Pathol,2011,64(7):553-560.
  • 5Lebeau A,Grob T,Holst F,et al. Oestrogen receptor gene (ESR1)amplification is frequent in endometrial carcinoma and its precursorlesions[J].J Pathol,2008,216(2): 151-157.
  • 6Banno K,Kisu I,Yanokura M,et al. Biomarkers in endometrialcancer:Possible clinical applications (Review) [J]. Oncol Lett,2012,3(6):1175-1180.
  • 7Wik E, Rasder MB, Krakstad C ,et al. Lack of estrogen receptor-ct isassociated with epithelial -mesenchymal transition and PI3Kalterations in endometrial carcinoma [J]. Clin Cancer Res,2013,19.5):1094-1105.
  • 8Smuc T,Rizner TL. Aberrant pre-receptor regulation of estrogen andprogesterone action in endometrial cancer [J]. Mol Cell Endocrinol,2009,301(1/2):74-82.
  • 9Haring J,Skrzypczak M,Stegerer A,et al. Estrogen receptor Ptranscript variants associate with oncogene expression in endometrialcancer[J]. Int J Mol Med,2012,29(6) : 1127-1136.
  • 10Jongen V,Briet J,de Jong R,et al. Expression of estrogen receptor-aipha and -beta and progesterone receptor -A and -B in a largecohort of patients with endometrioid endometrial cancer [J]. GynecolOncol,2009,112(3): 537-542.

同被引文献26

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部